EAC Meeting Program

Jointly Provided by: the American College of Allergy, Asthma & Immunology (ACAAI)
and the Eastern Allergy Conference (EAC) 

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology and the Eastern Allergy Conference.  The American College of Allergy, Asthma and Immunology is accredited by the ACCME to provide continuing medical education for physicians.

Designation

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 15.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by educational grants from commercial interests. Complete information will be provided to participants prior to the activity.

In compliance with the Americans with Disabilities Act, EAC requests that any participant in need of accommodations submit a written request to EAC well in advance.  

Please contact Ginny Loiselle at 401-223-1309 or GinnyLoiselle@easternallergyconference.org. 

Thursday, May 30, 2019

4:30 – 5:05 Biologics for allergic skin diseases: Chronic urticaria and atopic dermatitis

                    Dennis Ledford, MD 

5:05 – 5:10 Q & A

5:10 – 5:45 Don’t miss these mimickers of urticaria and atopic dermatitis

                    Neill Peters, MD 

5:45 – 5:50 Q & A

5:50 – 6:25 Advancements in the diagnosis and treatment of HAE

                    David Khan, MD 

6:25 – 6:30 Q & A

Friday, May 31, 2019

7:45 – 8:15 Severe asthma: Diagnosis and burden of illness 

                     John Oppenheimer, MD 

8:15 – 8:45 Corticosteroid stewardship

                    Dennis Ledford, MD

8:45 – 8:55 Q & A

8:55 – 10:00 PBL:  A 44-year old man with  chronic cough and wheeze 

                     Ray Davis, MD

10:00 – 10:45  Coffee Break: Visit Exhibits and Posters

10:45 – 11:10 Severe asthma: Comorbidities

                     Anju Peters, MD

11:10 – 11:35 Biomarkers in severe asthma

                     Stanley Szefler, MD 

11:35 – 12:00 Phenotypic classification of allergic disease based on a new T2-high and T2- low  endotypic classification: Implications for diagnosis and choosing the right biologic for your patient

                     Joseph Bellanti, MD

12:00 – 12:15 Q & A

1:15 – 1:45 Targets in use of biologics for asthma

                    John Oppenheimer, MD

1:45 – 2:15 What comparison can be fairly made among biologics for severe asthma

                   Stephen Peters, MD 

2:15 – 2:45 The role of shared decision making in the selection of biologics for severe asthma

                   Don Bukstein, MD

2:45 – 3:00 Q & A

Saturday, June 1, 2019

7:45 – 8:15 Incorporating virtual visits into your allergy and immunology practice

                   Jay Portnoy, MD 

8:15 – 8:20 Q & A

8:20 – 8:50 Peanut allergy: Burden of illness

                  Marcus Shaker, MD

8:50 – 8:55 Q & A

8:55 – 10:00 PBL:  An 8-year-old boy with peanut allergy

                  Ray Davis, MD

10:00 – 10:45  Coffee Break: Visit Exhibits and Posters

10:45 – 11:10 Peanut challenges: Who? When? Where and How?

                  Jay Lieberman, MD

11:10 – 11:35 Advances in the management of peanut allergy (EPIT vs OIT)

                  Julie Wang, MD 

11:35 – 12:00 Cost effectiveness of peanut allergy management strategies 

                 Marcus Shaker, MD 

12:00 – 12:15 Q & A

1:15 – 1:45 Personalized therapy for common variable immunodeficiency (CVID)

                   Francisco Bonilla, MD 

1:45 – 1:50 Q & A

1:50 – 2:20 Mast cell disorders and idiopathic anaphylaxis: Evaluation and management

                   Phil Lieberman, MD

2:20 – 2:25 Q & A

2:25 – 2:55 Incorporating digital health into the practice of allergy and immunology

                    Melinda Rathkopf, MD

2:55 – 3:00 Q & A

Sunday, June 2, 2019

8:00 – 8:30 Biologics in the management of CRS: Are we there yet?

                    Anju Peters, MD

8:30 – 8:35 Q & A

8:35 – 9:05 Preventing and managing wheezing episodes in young children: The role of inhaled and systemic steroids

                    Stanley Szefler, MD 

9:05 – 9:15 Q & A

9:15 – 9:45 AIT: Strategies to improve efficacy and minimize adverse reactions

                    David Bernstein, MD

9:45 – 9:50 Q & A

9:50 – 10:20 Proactive management of penicillin and other antibiotic allergies

                    David Khan, MD 

10:20 – 10:30 Q & A

Non-CME Programming – Ponce de Leon 1, 2 & 3

Thursday, May 30, 2019:  

3:30 – 4:15pm  Product Theater (Not for CME)

6:35 – 7:20pm Product Theater (Not for CME)

Friday, May 31, 2019:  

6:55 – 7:40am Product Theater (Not for CME)

12:20 – 1:05pm  Product Theater (Not for CME)

Saturday, June 1, 2019: 

6:55 – 7:40am  Product Theater (Not for CME)

12:20 – 1:05pm  Product Theater (Not for CME)

Sunday, June 2, 2019 

7:10 - 7:55am  Product Theater (Not for CME)

Joseph Bellanti, MD 

David Bernstein, MD

Francisco Bonilla, MD 

Don Bukstein, MD

Ray Davis, MD

David Khan, MD 

Dennis Ledford, MD

Jay Lieberman, MD

Phil Lieberman, MD

John Oppenheimer, MD

Anju Peters, MD

Neill Peters, MD

Stephen Peters, MD

Jay Portnoy, MD 

Melinda Rathkopf, MD

Russell Settipane, MD

Marcus Shaker, MD

Stanley Szefler, MD

Julie Wang, MD